Prognostic Impact of Inflammation-Based Scores for Extrahepatic Cholangiocarcinoma
- 20 January 2022
- journal article
- research article
- Published by S. Karger AG in Digestive Surgery
- Vol. 39 (2-3) , 65-74
Abstract
Introduction: Although the relationship between systemic inflammatory responses and prognosis has been known in various cancers, it remains unclear which scores are most valuable for determining the prognosis of extrahepatic cholangiocarcinoma. We aimed to verify the usefulness of various inflammation-based scores as prognostic factors in patients with resected extrahepatic cholangiocarcinoma. Methods: We analyzed consecutive patients undergoing surgical resection for extrahepatic cholangiocarcinoma at our institution between January 2000 and December 2019. The usefulness of the following inflammation-based scores as prognostic factor was investigated: glasgow prognostic score (GPS), modified GPS, neutrophil-to-lymphocyte ratio, platelet to lymphocyte ratio, lymphocyte-to-monocyte ratio, prognostic nutrition index, C-reactive protein to albumin ratio (CAR), controlling nutritional status (CONUT), and prognostic index. Results: A total of 169 patients were enrolled in this study. Of the nine scores, CAR and CONUT indicated prognostic value. Furthermore, multivariate analysis for overall survival revealed that high CAR (>0.23) was an independent prognostic factor (hazard ratio: 1.816, 95% confidence interval: 1.135–2.906, p = 0.0129), along with lymph node metastasis and curability. There was no difference in tumor staging and short-term outcomes between the low CAR (≤0.23) and high CAR groups. Conclusions: CAR was the most valuable prognostic score in patients with resected extrahepatic cholangiocarcinoma.Keywords
This publication has 11 references indexed in Scilit:
- Preoperative hypoalbuminemia is associated with worse outcomes in colon cancer patientsClinical Nutrition, 2017
- Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct CancerJournal of Gastrointestinal Surgery, 2016
- Cancer-related inflammation and treatment effectivenessThe Lancet Oncology, 2014
- The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNMAnnals of Surgical Oncology, 2010
- C-reactive protein in liver cancer surgeryEuropean Journal of Surgical Oncology, 2008
- An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancerProceedings of the Nutrition Society, 2008
- Distal Bile Duct Carcinoma: Prognostic Factors After Curative Surgery. A Series of 112 CasesAnnals of Surgical Oncology, 2006
- The Cancer Cachexia Syndrome: A Review of Metabolic and Clinical ManifestationsNutrition in Clinical Practice, 2005
- Systemic inflammatory response predicts survival following curative resection of colorectal cancerBritish Journal of Surgery, 2003
- Interleukin‐6 functions as an autocrine growth factor in a cholangiocarcinoma cell lineJournal of Gastroenterology and Hepatology, 1994